These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 24498388)

  • 1. Loss of WISP2/CCN5 in estrogen-dependent MCF7 human breast cancer cells promotes a stem-like cell phenotype.
    Ferrand N; Gnanapragasam A; Dorothee G; Redeuilh G; Larsen AK; Sabbah M
    PLoS One; 2014; 9(2):e87878. PubMed ID: 24498388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting WNT1-inducible signaling pathway protein 2 alters human breast cancer cell susceptibility to specific lysis through regulation of KLF-4 and miR-7 expression.
    Akalay I; Tan TZ; Kumar P; Janji B; Mami-Chouaib F; Charpy C; Vielh P; Larsen AK; Thiery JP; Sabbah M; Chouaib S
    Oncogene; 2015 Apr; 34(17):2261-71. PubMed ID: 24931170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PARP3 controls TGFβ and ROS driven epithelial-to-mesenchymal transition and stemness by stimulating a TG2-Snail-E-cadherin axis.
    Karicheva O; Rodriguez-Vargas JM; Wadier N; Martin-Hernandez K; Vauchelles R; Magroun N; Tissier A; Schreiber V; Dantzer F
    Oncotarget; 2016 Sep; 7(39):64109-64123. PubMed ID: 27579892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matricellular Protein WISP2 Is an Endogenous Inhibitor of Collagen Linearization and Cancer Metastasis.
    Janjanam J; Pano G; Wang R; Minden-Birkenmaier BA; Breeze-Jones H; Baker E; Garcin C; Clayton G; Shirinifard A; Zaske AM; Finkelstein D; Labelle M
    Cancer Res; 2021 Nov; 81(22):5666-5677. PubMed ID: 34385183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocorticoids induce CCN5/WISP-2 expression and attenuate invasion in oestrogen receptor-negative human breast cancer cells.
    Ferrand N; Stragier E; Redeuilh G; Sabbah M
    Biochem J; 2012 Oct; 447(1):71-9. PubMed ID: 22765757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Twist modulates breast cancer stem cells by transcriptional regulation of CD24 expression.
    Vesuna F; Lisok A; Kimble B; Raman V
    Neoplasia; 2009 Dec; 11(12):1318-28. PubMed ID: 20019840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-6-induced epithelial-mesenchymal transition promotes the generation of breast cancer stem-like cells analogous to mammosphere cultures.
    Xie G; Yao Q; Liu Y; Du S; Liu A; Guo Z; Sun A; Ruan J; Chen L; Ye C; Yuan Y
    Int J Oncol; 2012 Apr; 40(4):1171-9. PubMed ID: 22134360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged mammosphere culture of MCF-7 cells induces an EMT and repression of the estrogen receptor by microRNAs.
    Guttilla IK; Phoenix KN; Hong X; Tirnauer JS; Claffey KP; White BA
    Breast Cancer Res Treat; 2012 Feb; 132(1):75-85. PubMed ID: 21553120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of vitamin D receptor in mammospheres: implications for vitamin D resistance in breast cancer and potential for combination therapy.
    Pervin S; Hewison M; Braga M; Tran L; Chun R; Karam A; Chaudhuri G; Norris K; Singh R
    PLoS One; 2013; 8(1):e53287. PubMed ID: 23341935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional heterogeneity within the CD44 high human breast cancer stem cell-like compartment reveals a gene signature predictive of distant metastasis.
    Leth-Larsen R; Terp MG; Christensen AG; Elias D; Kühlwein T; Jensen ON; Petersen OW; Ditzel HJ
    Mol Med; 2012 Sep; 18(1):1109-21. PubMed ID: 22692575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer stem-like cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial-mesenchymal transition in squamous cell carcinoma.
    Geng S; Guo Y; Wang Q; Li L; Wang J
    Arch Dermatol Res; 2013 Jan; 305(1):35-47. PubMed ID: 22740085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCN5, a novel transcriptional repressor of the transforming growth factor β signaling pathway.
    Sabbah M; Prunier C; Ferrand N; Megalophonos V; Lambein K; De Wever O; Nazaret N; Lachuer J; Dumont S; Redeuilh G
    Mol Cell Biol; 2011 Apr; 31(7):1459-69. PubMed ID: 21262769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different Effects of BORIS/CTCFL on Stemness Gene Expression, Sphere Formation and Cell Survival in Epithelial Cancer Stem Cells.
    Alberti L; Losi L; Leyvraz S; Benhattar J
    PLoS One; 2015; 10(7):e0132977. PubMed ID: 26185996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a GαGβγ, AKT and PKCα signalome associated with invasive growth in two genetic models of human breast cancer cell epithelial-to-mesenchymal transition.
    Ouelaa-Benslama R; De Wever O; Hendrix A; Sabbah M; Lambein K; Land D; Prévost G; Bracke M; Hung MC; Larsen AK; Emami S; Gespach C
    Int J Oncol; 2012 Jul; 41(1):189-200. PubMed ID: 22552300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IRE1 inhibition affects the expression of insulin-like growth factor binding protein genes and modifies its sensitivity to glucose deprivation in U87 glioma cells.
    Minchenko DO; Kharkova AP; Tsymbal DO; Karbovskyi LL; Minchenko OH
    Endocr Regul; 2015 Oct; 49(4):185-97. PubMed ID: 26494037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microenvironmental networks promote tumor heterogeneity and enrich for metastatic cancer stem-like cells in Luminal-A breast tumor cells.
    Weitzenfeld P; Meshel T; Ben-Baruch A
    Oncotarget; 2016 Dec; 7(49):81123-81143. PubMed ID: 27835603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SLUG/SNAI2 and tumor necrosis factor generate breast cells with CD44+/CD24- phenotype.
    Bhat-Nakshatri P; Appaiah H; Ballas C; Pick-Franke P; Goulet R; Badve S; Srour EF; Nakshatri H
    BMC Cancer; 2010 Aug; 10():411. PubMed ID: 20691079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor-β-induced plasticity causes a migratory stemness phenotype in hepatocellular carcinoma.
    Malfettone A; Soukupova J; Bertran E; Crosas-Molist E; Lastra R; Fernando J; Koudelkova P; Rani B; Fabra Á; Serrano T; Ramos E; Mikulits W; Giannelli G; Fabregat I
    Cancer Lett; 2017 Apr; 392():39-50. PubMed ID: 28161507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ATF3, an adaptive-response gene, enhances TGF{beta} signaling and cancer-initiating cell features in breast cancer cells.
    Yin X; Wolford CC; Chang YS; McConoughey SJ; Ramsey SA; Aderem A; Hai T
    J Cell Sci; 2010 Oct; 123(Pt 20):3558-65. PubMed ID: 20930144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of Six1 in luminal breast cancers predicts poor prognosis and promotes increases in tumor initiating cells by activation of extracellular signal-regulated kinase and transforming growth factor-beta signaling pathways.
    Iwanaga R; Wang CA; Micalizzi DS; Harrell JC; Jedlicka P; Sartorius CA; Kabos P; Farabaugh SM; Bradford AP; Ford HL
    Breast Cancer Res; 2012 Jul; 14(4):R100. PubMed ID: 22765220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.